factual
Drug development is genuinely expensive and risky
Bringing a new cancer drug to market costs an estimated $750 million to several billion dollars because efficacy must usually be shown in large randomized controlled trials, many promising drugs fail that test, companies run multiple trials to ensure one succeeds, and differing FDA and European endpoints force larger trials; this high cost is a legitimate reason a high price is needed as an incentive.
factualpending
Speaker
Vincent RajkumarEvidence Quote
“it's just very expensive to develop a new drug. So, I grant that, if you are going to invest in such a high-risk proposition, you should have some way of making that money back”
Created: 6/13/2026, 12:13:30 AM
Your notes
Loading notes...